+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oral Peptide Drugs Market - Global Forecast 2025-2030- Product Image
Oral Peptide Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Oral Peptide Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121564
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Amid rapid advances in formulation technologies and regulatory science, the oral peptide drugs market is experiencing a pivotal transformation. As innovations enable the shift from injectable to oral peptide therapeutics, senior decision-makers face new challenges and opportunities in product development, supply chain optimization, and market entry strategy.

Market Snapshot: Oral Peptide Drugs Market

The global oral peptide drugs market is undergoing robust expansion, characterized by notable breakthroughs in drug delivery, increased adoption across chronic and acute disease areas, and greater alignment among key industry participants. With an increasingly diverse pipeline and dynamic regional interests, the sector is poised for sustained growth supported by evolving healthcare infrastructure and strategic collaborations.

Scope & Segmentation of the Oral Peptide Drugs Market

This comprehensive research report examines the oral peptide therapeutic landscape through detailed segmentation and technological perspectives:

  • Therapeutic Applications: Cardiovascular disorders, diabetes (including DPP-4 inhibitors, GLP-1 analogues, insulin peptides), gastrointestinal disorders, oncology (covering kinase inhibitors and peptide vaccines).
  • Formulation Types: Capsules, oral solutions, oral suspensions, tablets.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • End Users: Clinics, home care settings, hospitals, specialty centers.
  • Molecule Typologies: Modified peptides, native peptides, peptide mimetics.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Russia, United Arab Emirates, South Africa, and others), and Asia-Pacific (including China, India, Japan, Australia, Singapore, and additional key markets).
  • Key Industry Participants: Organizations such as Novo Nordisk A/S, AstraZeneca PLC, Pfizer Inc., Eli Lilly and Company, Amgen Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Roche Holding AG, Merck & Co., Inc., and Boehringer Ingelheim International GmbH.

Key Takeaways from the Oral Peptide Drugs Market

  • Industry stakeholders are prioritizing collaborative innovation throughout the commercialization cycle, leveraging partnerships with academic, CRO, and CMO entities to advance oral peptide delivery solutions.
  • Growth in patient adherence and access is being driven by robust advances in oral administration, reducing traditional barriers associated with injectable peptide therapies.
  • Technological advances, such as protective coatings and permeation enhancers, are expanding the therapeutic reach of peptides, especially in the context of chronic disease management and immuno-oncology applications.
  • Global expansion strategies increasingly consider region-specific regulatory pathways and reimbursement dynamics, influencing how market leaders execute launches and sustain competitive advantage.
  • Vertical integration and investment in domestic production are reshaping supply chain efficiencies while navigating evolving cost structures and trade environments.
  • Attention to molecule stability, scalability, and patient-centric drug formats supports differentiation across development pipelines.

Tariff Impact: Navigating the 2025 United States Tariff Regime

Revised tariffs implemented in 2025 are materially affecting oral peptide drug supply chains and import dynamics. Companies are reevaluating supplier agreements, shifting critical manufacturing activities to favorable jurisdictions, and increasing domestic production investments. The resulting changes place greater scrutiny on final product landed costs and inform emerging pricing and contracting strategies within payer negotiations and healthcare delivery systems. These developments have realigned geographic supply chain footprints and heightened the focus on logistical agility for commercial success.

Methodology & Data Sources

This report integrates primary insights from structured interviews with clinicians, scientists, regulatory experts, and commercial leaders, complemented by secondary research from scientific literature, patents, and regulatory documents. Proprietary database analysis, trade and tariff data, and regional policy reviews underpin the findings. Insights were validated through multi-stage expert workshops to ensure accuracy and depth.

Why This Report Matters

  • Enables informed decision-making by delivering a granular understanding of oral peptide drug market segmentation, regulatory shifts, and innovation trends.
  • Offers actionable guidance for optimizing supply chain, manufacturing, and commercial strategies amid ongoing regulatory changes and competitive pressures.
  • Facilitates strategic planning by highlighting partnership models, tariff risks, and region-specific opportunities relevant to executive and operational leadership.

Conclusion

Oral peptide drugs are reframing treatment paradigms and driving multi-regional growth. An integrated, cross-functional approach—aligned with evolving technology, policy, and market forces—supports leaders in capturing new opportunities and mitigating operational complexity. The value chain will reward those prepared to innovate and execute with agility as conditions continue to evolve.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Innovations in oral absorption enhancers to significantly improve peptide bioavailability in the gastrointestinal tract
5.2. Development of targeted release formulation technologies for enhanced oral peptide delivery and stability
5.3. Surge in clinical trials of oral GLP-1 receptor agonists for type 2 diabetes leveraging advanced formulation platforms
5.4. Expansion of oral insulin analog pipelines integrating next generation protease inhibitors for improved therapeutic outcomes
5.5. Strategic alliances between biotech developers and contract research organizations to accelerate oral peptide approval timelines
5.6. Adoption of lipid nanoparticle encapsulation methods to protect orally delivered peptides from enzymatic degradation
5.7. Evolution of global regulatory frameworks streamlining expedited review pathways for oral peptide therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oral Peptide Drugs Market, by Therapeutic Application
8.1. Introduction
8.2. Cardiovascular Disorders
8.3. Diabetes
8.3.1. DPP-4 Inhibitors
8.3.2. GLP-1 Analogues
8.3.3. Insulin Peptides
8.4. Gastrointestinal Disorders
8.5. Oncology
8.5.1. Kinase Inhibitors
8.5.2. Peptide Vaccines
9. Oral Peptide Drugs Market, by Form
9.1. Introduction
9.2. Capsules
9.3. Oral Solutions
9.4. Oral Suspensions
9.5. Tablets
10. Oral Peptide Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Oral Peptide Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
11.5. Specialty Centers
12. Oral Peptide Drugs Market, by Molecule Type
12.1. Introduction
12.2. Modified Peptides
12.3. Native Peptides
12.4. Peptide Mimetics
13. Americas Oral Peptide Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Oral Peptide Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Oral Peptide Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk a/S
16.3.2. AstraZeneca PLC
16.3.3. Pfizer Inc.
16.3.4. Eli Lilly and Company
16.3.5. Amgen Inc.
16.3.6. Sanofi S.A.
16.3.7. Takeda Pharmaceutical Company Limited
16.3.8. Roche Holding AG
16.3.9. Merck & Co., Inc.
16.3.10. Boehringer Ingelheim International GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ORAL PEPTIDE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ORAL PEPTIDE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ORAL PEPTIDE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ORAL PEPTIDE DRUGS MARKET: RESEARCHAI
FIGURE 26. ORAL PEPTIDE DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. ORAL PEPTIDE DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. ORAL PEPTIDE DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ORAL PEPTIDE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DPP-4 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DPP-4 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY GLP-1 ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY GLP-1 ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY INSULIN PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY INSULIN PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY KINASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY KINASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY MODIFIED PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY NATIVE PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY NATIVE PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY PEPTIDE MIMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ORAL PEPTIDE DRUGS MARKET SIZE, BY PEPTIDE MIMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ORAL PEPTIDE DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 104. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 105. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 106. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 107. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 190. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 191. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 194. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 195. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 204. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 205. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 206. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 207. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 208. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 209. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 232. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 233. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 234. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 235. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 236. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 237. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 246. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 247. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 248. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 249. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 250. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 251. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 256. SPAIN ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 302. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 303. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 304. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 305. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 306. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 307. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 312. DENMARK ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 327. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 330. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 331. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 332. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 333. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 334. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 335. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 340. QATAR ORAL PEPTIDE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 341. FINLAND ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. FINLAND ORAL PEPTIDE DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. FINLAND ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 344. FINLAND ORAL PEPTIDE DRUGS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Oral Peptide Drugs market report include:
  • Novo Nordisk A/S
  • AstraZeneca PLC
  • Pfizer Inc.
  • Eli Lilly and Company
  • Amgen Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Roche Holding AG
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH

Related Reports

Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030 - Product Image

Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030

  • Report
  • 326 Pages
  • Global
From
GLP-1 Targeted Peptide Weight Loss Drugs Market - Global Forecast 2025-2030 - Product Image

GLP-1 Targeted Peptide Weight Loss Drugs Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Collagen Peptide Oral Solution Market - Global Forecast 2025-2030 - Product Image

Collagen Peptide Oral Solution Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Oral Proteins and Peptides - Global Strategic Business Report - Product Image

Oral Proteins and Peptides - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.